Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
WASHINGTON (Reuters) - U.S. Health and Human Services Secretary Xavier Becerra said on Friday the government will try to ...
Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be ...
The price negotiations almost assures billions of dollars in savings for taxpayers.
A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold, potentially eliminating ...
A drug interception this week at the Brownsville and Matamoros International Bridge resulted in officers finding $158,145 ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback